[CD20 antibody for treatment of rheumatoid arthritis].
Tanaka
Yoshiya
Y
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab